Creso Pharma Limited (COPHF) Stock Overview
Explore Creso Pharma Limited’s financial performance, market position, analyst ratings, and future outlook.
Creso Pharma Limited (COPHF)
Key Financials
Key Financials
Market Cap
131.7M
P/E Ratio
0.00
EPS (TTM)
$-5.08
ROE
-5.75%
COPHF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Creso Pharma Limited (COPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 131.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.